ADVFN ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Apollo Series 2017 2 Trust

Apollo Series 2017 2 Trust (AO2HA)

0.00
0.00
(0.00%)
Cerrado 24 Junio 1:00AM

Apollo Series 2017 2 Trust (AO2HA) Cotización

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
-
( - )
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
-
Precio de Apertura
-
Hora
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

AO2HA Últimas noticias

No hay noticias para mostrar aún.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

AO2HA - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Apollo Series 2017 2 Trust?
El precio actual de las acciones de Apollo Series 2017 2 Trust es AUD 0.00
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Apollo Series 2017 2 Trust?
Apollo Series 2017 2 Trust ha negociado en un rango de AUD 0.00 a AUD 0.00 durante el último año

AO2HA Operaciones

Más

Operaciones con retraso

Para obtener operaciones en tiempo real, actualice su cuenta

Actualizar a tiempo real
mm41 mm41 10 minutos hace
Some of the things I write and share here publicly are not exactly popular among the members of this platform. I can understand that, because imagine someone who is a fund manager, cutting off the branch they are sitting on. A little bit of humor doesn't hurt, right? Sometimes I am too direct, but t
QQQ
US Market News US Market News 15 minutos hace
Signatera™ Receives Regulatory Approval in Japan for Colorectal CancerJune 24, 2026 5:00 AM
Business WireFirst PMDA-approved molecular residual disease (MRD) test in Japan, supporting the use of Signatera in the adjuvant settingCommercia
NTRA
MightyX MightyX 18 minutos hace
110M+ volume first hour
ADTX
Frankestin Frankestin 20 minutos hace
BLA submission triggers at hazard ratio at or below 0.6. Phase 2 median OS for the exact Phase 3 formulation was 16.6 months versus approximately 8 months for TPC, implied hazard ratio of approximately 0.48. Well inside the submission zone.
Enrollment: 315 screened and 230 enrolled as of May
BCTX
Mr79 Mr79 27 minutos hace
https://media0.giphy.com/media/v1.Y2lkPTZjMDliOTUybnQzZTJ0Mzc5Z255ZTN3OXcweGdpZmE5emhhNTljaDFoYjhncXIyMCZlcD12MV9pbnRlcm5hbF9naWZfYnlfaWQmY3Q9Zw/FoH28ucxZFJZu/giphy.gifhttps://media1.giphy.com/media/v1.Y2lkPTZjMDliOTUyNDlhaGRnenBrODJ5aXd3Z3Y5c3E3NmV6eXo1c3ZramF2amV6eXRsOCZlcD12MV9pbnRlcm5hbF9naWZfYn
CNNA
William777 William777 29 minutos hace
AI technology is coming. It's a new day. Infrastructure that will change everything. Like I've said before, expect the unexpected.
NNRX
Ace Trader Ace Trader 30 minutos hace
2 ideas I have!

1, waiting for news of the creation of the SWF and adding F-2 and other Gov investments to it. All those lending agencies, Farmer Mac, Freddie Mac, Fannie Mae etc into the SWF. The news released on Americas 250 birthday the release plan. There's his $1 Trillion Market
FNMA
US Market News US Market News 30 minutos hace
Morningstar Sustainalytics Enhances Physical Climate Risk Capabilities with XDI and VeridionJune 24, 2026 4:36 AM
Business Wire Dataset is designed to translate asset-level climate hazards into risk metrics for investors Morningstar Sustainalytics, a leading provider of
MORN
Chuck McQuade Chuck McQuade 32 minutos hace
Just keep the apology short and to the point. I think we are on the same team.
WNFT
Chuck McQuade Chuck McQuade 39 minutos hace
WNFT
MightyX MightyX 39 minutos hace
Up 10% first 100m volume
ADTX
CA Market News CA Market News 45 minutos hace
Fortune Minerals Announces Results of Annual and Special Meeting of ShareholdersJune 24, 2026 4:20 AM
Business Wire Fortune Minerals Limited (TSX: FT) (OTCQB: FTMDF) (“Fortune” or the “Company”) (
FTMDF
boston127 boston127 53 minutos hace
Volume is 85M, .048 price.

4:20 AM.
ADTX
gregcod gregcod 55 minutos hace
Tom Terrific! You got this!..Something is Up! I scolled down after reading it was Norma Garcia being awarded those shares that she could sell at .368 or so ,,something like thati Something good.IMO.In our opinion..Trader..You on this? Ya just dont keep rearding shares without a event thats going t
IBATF
Golden Cross Golden Cross 56 minutos hace
$WNW Looking for a PM move here...Getting Volume early 3.74
WNW
amelia43 amelia43 58 minutos hace
How so?

Is Iran really over
FNMA
Golden Cross Golden Cross 58 minutos hace
$WNW Looking for a PM move here...Getting Volume early
WNW
MegaElf9 MegaElf9 59 minutos hace
Thanks! Seems realistic indeed. Any price targets for next week, or eom?

Cheers & have a good week!
MTEN
throw me a bone throw me a bone 59 minutos hace
Mexedia announces the reduction of its shareholding in Telvantis to 49%

full statement at mexida website under press releases. Any opinions on weather this is good or bad for us?
RDAR
eagle8 eagle8 60 minutos hace
d_stock
@d_stock07734
$NWBO

$NWBO probably can produce DC vaccines pulsed with either allogenic tumor lysate or synthetic peptides from a biobank. That means that surgery may not be needed.

But cancer patients have to go through leukapheresis procedure to
NWBO
EmpressRealm45 EmpressRealm45 1 hora hace
Planning to add more tomorrow - Ackman’s prediction on timing seems to align well
FNMA
FlashySage44 FlashySage44 1 hora hace
Elite, please uplist to the Nasdaq.
My tax free account is waiting for you with open arms.
I can’t buy it in my tax free account while it’s OTC and I already maxed out how much I can buy as there is a limit.
ELTP
Investor2014 Investor2014 1 hora hace
Based on the limited information available, this appears to mean that drug makers may, in suitable cases, be able to achieve approval based on one rigorous, well-controlled pivotal Phase 3 trial plus confirmatory evidence, rather than multiple pivotal trials.
In late-stage development, drugma
AVXL
boston127 boston127 1 hora hace
4:01 AM, and already .045 with 20M

shares traded. Up 9% and not looking back.
ADTX
US Market News US Market News 1 hora hace
Coretura and Accenture Join Forces to Reinvent the Development of Software-Defined Commercial VehiclesJune 24, 2026 3:59 AM
Business Wire Engineering collaboration brings together deep automotive expertise and the ambition to provide one software platform, lang
ACN

Su Consulta Reciente

Delayed Upgrade Clock